Author: Patrick van der Valk

xUTILITY to Lead the Way Integrating Research and Patient Care

Seamless integration with existing healthcare infrastructures drives unprecedented possibilities to improve medical research and patient care. xCures, a trailblazer in healthcare technology, is delighted to unveil xUTILITY, a solution poised to transform the patient registry paradigm in the United States. xUTILITY establishes an instantaneous patient registry platform by retrieving records… Read more »

xCures to Contribute Data to Support Aetion®’s Collaboration with FDA

xCures data deemed fit-for-purpose to address research questions relevant to the prevention, clinical care, diagnostics, and treatment in oncology. First posted on NewsDirect In a step forward for healthcare research, xCures is pleased to announce that it will support Aetion®’s collaboration with the US Food and Drug Administration (FDA) Oncology… Read more »

CureMatch and xCures Partner to Revolutionize the Standard for Precision Cancer Treatment Processes

CureMatch will leverage the xCures technology that automatically creates a comprehensive outline of a cancer patient’s medical history in order to improve treatment recommendations. CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, is proud to announce a partnership with xCures,… Read more »

xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study

RenovoRx’s Phase III clinical study is open to pancreatic adenocarcinoma patients and focuses on extending overall survival and improving quality of life. [EINPresswire] xCures, Inc. is proud to announce their partnership with RenovoRx, a clinical-stage biopharmaceutical company that focuses on fighting cancer through localized treatment of difficult-to-treat tumors, such as… Read more »